Renaxen 5 — Axitinib 5 mg, 60 product-page.units_short, Everest
100% original product

Renaxen 5 Tablets — Axitinib 5 mg (60 Tabs) Everest

26333 30722 -14%

Renaxen 5 mg (Axitinib) is a potent and selective tyrosine kinase inhibitor targeting vascular endothelial growth factor receptors (VEGFR-1, -2, and -3). It serves as a cost-effective generic equivalent to Inlyta. By inhibiting these receptors, Axitinib blocks angiogenesis (the formation of new blood vessels), effectively starving the tumor of nutrients and oxygen.

Manufacturer: Everest Pharmaceuticals (Bangladesh). The 5 mg strength represents the standard starting dose for the treatment of advanced renal cell carcinoma.

Key Features:

  • Anti-Angiogenic Mechanism: Directly halts the blood supply to the tumor, inhibiting its growth.
  • Advanced RCC Standard: Proven efficacy in treating kidney cancer after failure of prior systemic treatments.
  • Monthly Supply: The box is designed to cover exactly one month of treatment at the standard dosage.

Prescribed by oncologists for the treatment of adult patients with:

  • 🔹 Advanced Renal Cell Carcinoma (RCC): Specifically indicated after failure of one prior systemic therapy (e.g., sunitinib or cytokine-based regimens).

Sales Unit: Box containing 60 film-coated tablets (5 mg strength). This provides exactly a 30-day supply.

⚠️ APPLICATION INSTRUCTIONS:

  • Standard Dosage: 5 mg (one tablet) taken orally twice daily.
  • Administration: Take doses approximately 12 hours apart. Can be taken with or without food. Swallow whole with a full glass of water. Do not crush or chew.
  • Missed Dose: If a dose is missed or vomiting occurs, do not take an extra dose. Resume the regular schedule at the next time.
  • Adjustment: Dosage may be titrated by the physician based on individual safety and tolerability.
  • Pregnancy & Breastfeeding: Strictly contraindicated. Can cause fetal harm.
  • Hypersensitivity to Axitinib.
  • Severe hepatic impairment (Child-Pugh Class C).
  • History of arterial thromboembolic events (stroke, heart attack) within the last 12 months.
  • Uncontrolled hypertension.

Blood pressure and thyroid function must be monitored regularly. Potential side effects include:

  • 📈 Hypertension: High blood pressure (very common).
  • 🤢 Gastrointestinal: Diarrhea, nausea, vomiting, decreased appetite.
  • 🗣️ Dysphonia: Hoarseness or voice changes.
  • 🦋 Thyroid: Hypothyroidism (low thyroid hormone levels).
  • Skin: Hand-Foot Syndrome (Palmar-plantar erythrodysesthesia).
Active ingredient
Manufacturer
Everest
Dosage 5 mg
Dosage form Tablets
Tablets per pack 60
100% original product
Delivery across Ukraine
Alternatives

Similar products

Inlybest 5 mg Aprazer
View
Aprazer

Inlybest

5 mg 28 tablets
5267 5705
Renaxen 1 1 mg Everest
View
Everest

Renaxen 1

1 mg 120 tablets
30722 37305
Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00